(Q41686678)

7 October 2017

title

Reversal of multidrug resistance in HL-60 cells by verapamil and liposome-encapsulated doxorubicin (English)

1 reference

https://api.crossref.org/works/10.1016/0304-3835(91)90211-Y

26 October 2022

main subject

multiple drug resistance

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1016/0304-3835(91)90211-Y

26 October 2022

author name string

R. Sadasivan

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1673873

26 October 2022

R. Morgan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1673873

26 October 2022

C. Fabian

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1673873

26 October 2022

R. Stephens

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1673873

26 October 2022

language of work or name

English

0 references

publication date

1 May 1991

1 reference

full work available at URL

7 October 2017

https://api.elsevier.com/content/article/PII:030438359190211Y?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0304-3835(91)90211-Y

https://api.elsevier.com/content/article/PII:030438359190211Y?httpAccept=text/plain

26 October 2022

1 reference

https://api.crossref.org/works/10.1016/0304-3835(91)90211-Y

26 October 2022

1 reference

7 October 2017

volume

57

1 reference

7 October 2017

issue

2

1 reference

7 October 2017

page(s)

165-171

1 reference

Pleiotropic phenotype of colchicine-resistant CHO cells: cross-resistance and collateral sensitivity

7 October 2017

cites work

2

1 reference

https://api.crossref.org/works/10.1016/0304-3835(91)90211-Y

Cell Surface P-Glycoprotein Associated with Multidrug Resistance in Mammalian Cell Lines

26 October 2022

3

1 reference

https://api.crossref.org/works/10.1016/0304-3835(91)90211-Y

Genetic and biochemical characterization of multidrug resistance

26 October 2022

4

1 reference

https://api.crossref.org/works/10.1016/0304-3835(91)90211-Y

A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants

26 October 2022

5

1 reference

https://api.crossref.org/works/10.1016/0304-3835(91)90211-Y

Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines

26 October 2022

8

1 reference

https://api.crossref.org/works/10.1016/0304-3835(91)90211-Y

Human multidrug-resistant cell lines: increased mdr1 expression can precede gene amplification

26 October 2022

9

1 reference

https://api.crossref.org/works/10.1016/0304-3835(91)90211-Y

Expression of a multidrug resistance gene in human cancers

26 October 2022

10

1 reference

https://api.crossref.org/works/10.1016/0304-3835(91)90211-Y

Isolation and characterization of DNA sequences amplified in multidrug-resistant hamster cells

26 October 2022

11

1 reference

https://api.crossref.org/works/10.1016/0304-3835(91)90211-Y

Isolation and expression of a complementary DNA that confers multidrug resistance

26 October 2022

12

1 reference

https://api.crossref.org/works/10.1016/0304-3835(91)90211-Y

Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells.

26 October 2022

15

1 reference

https://api.crossref.org/works/10.1016/0304-3835(91)90211-Y

ATP-dependent transport of vinblastine in vesicles from human multidrug-resistant cells

26 October 2022

17

1 reference

https://api.crossref.org/works/10.1016/0304-3835(91)90211-Y

Cyclosporin A corrects daunorubicin resistance in Ehrlich ascites carcinoma

26 October 2022

22

1 reference

https://api.crossref.org/works/10.1016/0304-3835(91)90211-Y

Verapamil and adriamycin in the treatment of drug-resistant ovarian cancer patients

26 October 2022

23

1 reference

https://api.crossref.org/works/10.1016/0304-3835(91)90211-Y

Drug-carrier potential of liposomes in cancer chemotherapy

26 October 2022

24

1 reference

https://api.crossref.org/works/10.1016/0304-3835(91)90211-Y

Pharmacokinetics of liposome-encapsulated anti-tumor drugs. Studies with vinblastine, actinomycin D, cytosine arabinoside, and daunomycin

26 October 2022

25

1 reference

https://api.crossref.org/works/10.1016/0304-3835(91)90211-Y

Antitumor and toxicity evaluation of free doxorubicin and doxorubicin entrapped in cardiolipin liposomes

26 October 2022

26

1 reference

https://api.crossref.org/works/10.1016/0304-3835(91)90211-Y

Modulation of multidrug resistance in Chinese hamster cells by liposome-encapsulated doxorubicin

26 October 2022

29

1 reference

https://api.crossref.org/works/10.1016/0304-3835(91)90211-Y

A new, sensitive determination of phosphate

26 October 2022

31

1 reference

https://api.crossref.org/works/10.1016/0304-3835(91)90211-Y

Improved therapeutic benefits of doxorubicin by entrapment in anionic liposomes

26 October 2022

32

1 reference

https://api.crossref.org/works/10.1016/0304-3835(91)90211-Y

Multidrug resistance: molecular biology and clinical relevance.

26 October 2022

34

1 reference

https://api.crossref.org/works/10.1016/0304-3835(91)90211-Y

Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy.

26 October 2022

35

1 reference

https://api.crossref.org/works/10.1016/0304-3835(91)90211-Y

P-glycoprotein in human sarcoma: evidence for multidrug resistance

26 October 2022

37

1 reference

https://api.crossref.org/works/10.1016/0304-3835(91)90211-Y

A phase I clinical trial and pharmacokinetic evaluation of liposome-encapsulated doxorubicin

26 October 2022

39

1 reference

https://api.crossref.org/works/10.1016/0304-3835(91)90211-Y

26 October 2022

Identifiers

1 reference

7 October 2017

1 reference